| pubmed-article:8545383 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8545383 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
| pubmed-article:8545383 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8545383 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
| pubmed-article:8545383 | lifeskim:mentions | umls-concept:C0279030 | lld:lifeskim |
| pubmed-article:8545383 | lifeskim:mentions | umls-concept:C2242456 | lld:lifeskim |
| pubmed-article:8545383 | pubmed:issue | 35 | lld:pubmed |
| pubmed-article:8545383 | pubmed:dateCreated | 1996-2-13 | lld:pubmed |
| pubmed-article:8545383 | pubmed:abstractText | Four female patients had chronic hepatitis C associated with antithyroid autoantibodies. Hepatitis C virus infection was evidenced by liver biopsy and a positive-four-antigen recombinant immunoblot assay. All four patients were euthyroid before interferon therapy. Recombinant interferon alpha was given at a dose of 3 millions units three times a week for 6 months. At the end of the treatment, serum aminotransferase levels were within the normal range. Two patients progressed to hypothyroidism and 2 patients remained euthyroid. One year after the end of the treatment, only one patient had hypothyroidism and another had normal serum aminotransferase levels. These case-reports suggest that interferon administration may induce thyroid dysfunction in patients with antithyroid autoantibodies at the beginning of treatment. Thyroid dysfunction may be reversed when cytokine is withdrawn. | lld:pubmed |
| pubmed-article:8545383 | pubmed:language | fre | lld:pubmed |
| pubmed-article:8545383 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8545383 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8545383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8545383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8545383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8545383 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8545383 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:8545383 | pubmed:issn | 0755-4982 | lld:pubmed |
| pubmed-article:8545383 | pubmed:author | pubmed-author:RampalPP | lld:pubmed |
| pubmed-article:8545383 | pubmed:author | pubmed-author:TranAA | lld:pubmed |
| pubmed-article:8545383 | pubmed:author | pubmed-author:QuarantaJ FJF | lld:pubmed |
| pubmed-article:8545383 | pubmed:author | pubmed-author:DreyfusGG | lld:pubmed |
| pubmed-article:8545383 | pubmed:author | pubmed-author:BenzakenSS | lld:pubmed |
| pubmed-article:8545383 | pubmed:author | pubmed-author:BroussardJ... | lld:pubmed |
| pubmed-article:8545383 | pubmed:author | pubmed-author:FrédenrichAA | lld:pubmed |
| pubmed-article:8545383 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8545383 | pubmed:day | 18 | lld:pubmed |
| pubmed-article:8545383 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:8545383 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8545383 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8545383 | pubmed:pagination | 1645-7 | lld:pubmed |
| pubmed-article:8545383 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:meshHeading | pubmed-meshheading:8545383-... | lld:pubmed |
| pubmed-article:8545383 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8545383 | pubmed:articleTitle | [Anti-thyroid autoantibodies in hepatitis C. Thyroid function after interferon therapy in 4 patients]. | lld:pubmed |
| pubmed-article:8545383 | pubmed:affiliation | Service d'Hépato-Gastroentérologie, Hôpital de l'Archet, Nice. | lld:pubmed |
| pubmed-article:8545383 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8545383 | pubmed:publicationType | English Abstract | lld:pubmed |
